170 related articles for article (PubMed ID: 9262358)
1. Prediction of in vivo hepatic metabolic clearance of YM796 from in vitro data by use of human liver microsomes and recombinant P-450 isozymes.
Iwatsubo T; Suzuki H; Shimada N; Chiba K; Ishizaki T; Green CE; Tyson CA; Yokoi T; Kamataki T; Sugiyama Y
J Pharmacol Exp Ther; 1997 Aug; 282(2):909-19. PubMed ID: 9262358
[TBL] [Abstract][Full Text] [Related]
2. Prediction of species differences (rats, dogs, humans) in the in vivo metabolic clearance of YM796 by the liver from in vitro data.
Iwatsubo T; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1997 Nov; 283(2):462-9. PubMed ID: 9353358
[TBL] [Abstract][Full Text] [Related]
3. Identification of human cytochrome P-450 isoforms involved in metabolism of R(+)- and S(-)-gallopamil: utility of in vitro disappearance rate.
Suzuki A; Iida I; Tanaka F; Akimoto M; Fukushima K; Tani M; Ishizaki T; Chiba K
Drug Metab Dispos; 1999 Nov; 27(11):1254-9. PubMed ID: 10534309
[TBL] [Abstract][Full Text] [Related]
4. Prediction of in vivo nonlinear first-pass hepatic metabolism of YM796 from in vitro metabolic data.
Iwatsubo T; Hisaka A; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1998 Jul; 286(1):122-7. PubMed ID: 9655850
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue.
Kuperman AV; Kalgutkar AS; Marfat A; Chambers RJ; Liston TE
Drug Metab Dispos; 2001 Nov; 29(11):1403-9. PubMed ID: 11602515
[TBL] [Abstract][Full Text] [Related]
6. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
Miyazawa M; Shindo M; Shimada T
Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
[TBL] [Abstract][Full Text] [Related]
8. Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes.
Shimada T; Tsumura F; Yamazaki H
Drug Metab Dispos; 1999 Nov; 27(11):1274-80. PubMed ID: 10534312
[TBL] [Abstract][Full Text] [Related]
9. Determination of the rate-limiting step in the hepatic elimination of YM796 by isolated rat hepatocytes.
Iwatsubo T; Suzuki H; Sugiyama Y
Pharm Res; 1999 Jan; 16(1):110-6. PubMed ID: 9950288
[TBL] [Abstract][Full Text] [Related]
10. In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol.
Usmani KA; Hodgson E; Rose RL
Chem Biol Interact; 2004 Dec; 150(3):221-32. PubMed ID: 15560889
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
Stringer RA; Strain-Damerell C; Nicklin P; Houston JB
Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847
[TBL] [Abstract][Full Text] [Related]
12. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans.
Naritomi Y; Terashita S; Kimura S; Suzuki A; Kagayama A; Sugiyama Y
Drug Metab Dispos; 2001 Oct; 29(10):1316-24. PubMed ID: 11560875
[TBL] [Abstract][Full Text] [Related]
13. Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes.
Subrahmanyam V; Renwick AB; Walters DG; Young PJ; Price RJ; Tonelli AP; Lake BG
Drug Metab Dispos; 2001 Aug; 29(8):1146-55. PubMed ID: 11454734
[TBL] [Abstract][Full Text] [Related]
14. A study on the metabolism of etoposide and possible interactions with antitumor or supporting agents by human liver microsomes.
Kawashiro T; Yamashita K; Zhao XJ; Koyama E; Tani M; Chiba K; Ishizaki T
J Pharmacol Exp Ther; 1998 Sep; 286(3):1294-300. PubMed ID: 9732391
[TBL] [Abstract][Full Text] [Related]
15. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
16. In vitro/in vivo scaling of alprazolam metabolism by CYP3A4 and CYP3A5 in humans.
Hirota N; Ito K; Iwatsubo T; Green CE; Tyson CA; Shimada N; Suzuki H; Sugiyama Y
Biopharm Drug Dispos; 2001 Mar; 22(2):53-71. PubMed ID: 11745908
[TBL] [Abstract][Full Text] [Related]
17. Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9, 2C19, and 3A4.
Komatsu T; Yamazaki H; Asahi S; Gillam EM; Guengerich FP; Nakajima M; Yokoi T
Drug Metab Dispos; 2000 Nov; 28(11):1361-8. PubMed ID: 11038165
[TBL] [Abstract][Full Text] [Related]
18. In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s.
Prueksaritanont T; Gorham LM; Ma B; Liu L; Yu X; Zhao JJ; Slaughter DE; Arison BH; Vyas KP
Drug Metab Dispos; 1997 Oct; 25(10):1191-9. PubMed ID: 9321523
[TBL] [Abstract][Full Text] [Related]
19. In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes.
Fang J; McKay G; Song J; Remillrd A; Li X; Midha K
Drug Metab Dispos; 2001 Dec; 29(12):1638-43. PubMed ID: 11717183
[TBL] [Abstract][Full Text] [Related]
20. Major pathway of imipramine metabolism is catalyzed by cytochromes P-450 1A2 and P-450 3A4 in human liver.
Lemoine A; Gautier JC; Azoulay D; Kiffel L; Belloc C; Guengerich FP; Maurel P; Beaune P; Leroux JP
Mol Pharmacol; 1993 May; 43(5):827-32. PubMed ID: 8502233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
